Decision aids and prostate cancer: how useful are they?

Your sitemaster has long had concerns about the real value of decision aids in helping men to think about and come to conclusions about controversial issues in the diagnosis and management of prostate cancer. … READ MORE …

Modern prostate cancer imaging: application of the right scan at the right time

A new “opinion” article in the Journal of Clinical Oncology this week has addressed the complex issue of how best to think about (a) how we are regulating use of and (b) how we are applying new forms of imaging technique in the management of prostate cancer … READ MORE …

What patients think and understand can impact their decisions and their outcomes

It has long been appreciated that African-American males have higher risk for diagnosis with prostate cancer, and higher risk for prostate cancer-specific mortality, than those of other ethnic origins living in the US. … READ MORE …

Salvage radiation dose: decision-making under uncertainty

A large, well-done, confirmed, randomized clinical trial (RCT) is the only evidence that proves that one therapy is better than other. According to current consensus, this is deemed “Level 1a” evidence. But this high level of evidence is seldom available. … READ MORE …

How can shared decision-making work well if we aren’t starting from the same point?

Now here is a very interesting set of data from (admittedly) a small pilot study by a group of Italian researchers. … READ MORE …

Why “patient-reported outcomes” are important

As regular readers will be aware, your sitemaster is a tad obsessed with the quality of “care” that patients receive from their healthcare providers (as opposed to “just” the quality of their diagnosis and treatment). … READ MORE …

Decision aids and decision-making in prostate cancer risk

Your sitemaster has long believed that, while electronic and other decision aids can be helpful in providing men with information and education about prostate cancer, their value in helping them to make the best decisions is less clear. … READ MORE …

Race and decision-making in prostate cancer management

An article in Oncology Nurse Advisor notes that “Black and white men prioritize certain treatment-related factors differently when considering prostate cancer treatment options.” … READ MORE …

Outcomes, side effects, quality of life, and choosing a treatment that works FOR YOU!

Three articles in this week’s Journal of the American Medical Association throw a little more light on issues related to quality of life after diagnosis and treatment for localized prostate cancer … but quite how much light it is difficult to tell. … READ MORE …

The impact of emotional distress on prostate cancer decision-making

According to a newly published paper in the Journal of Urology,

Emotional distress may motivate men with low risk prostate cancer to choose more aggressive treatment. Addressing emotional distress before and during treatment decision making may reduce a barrier to the uptake of active surveillance.

… READ MORE

Impact of OSGs on patient decision-making and treatment for localized prostate cancer

Since Prostate Cancer International runs an online support group (OSG) for patients, we were obviously very interested to see a newly published article by a German research group on the effects of OSGs on patients’ decision-making processes. … READ MORE …

A new set of risk strata to define prognostic risk for men with localized prostate cancer

A newly published paper in the journal PLoS Medicine has set out a new set of definitions of five “risk strata” into which we can subdivide men diagnosed with prostate cancer. … READ MORE …

Longer life or quality of life? What do newly diagnosed patients really want?

A third, and interesting, late-breaking poster to be presented at the upcoming annual meeting of the American Urological Association looked into patient perspectives on quality of life as opposed to quantity of life in prostate cancer treatment decision making. … READ MORE …

More from the EAU annual meeting in Munich

UroToday has provided a second set of reports on the key presentations given at the annual meeting of the European Association of Urology, being held this year in Munich, Germany. … READ MORE …

Contemporary treatment decision-making at an equal access, multidisciplinary, prostate cancer clinic

A new paper in Urologic Oncology describes what appears to be one of the first prospective cohort studies to examine treatment decision-making by newly diagnosed prostate cancer patients within a contemporary, racially diverse, equal access, multidisciplinary clinic setting. … READ MORE …